Modeling of Pharmacokinetics of Cocaine in Human Reveals the Feasibility for Development of Enzyme Therapies for Drugs of Abuse
Figure 3
Plots for the cocaine peak concentration (µM) in brain versus the initial concentration (µM) of cocaine in plasma in the presence of a cocaine-metabolizing enzyme (0.035 or 0.5 µM).